Working… Menu

Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01888562
Recruitment Status : Withdrawn (Could not obtain an IDE on the FGFR2 assay)
First Posted : June 27, 2013
Last Update Posted : December 18, 2015
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : July 2018
Estimated Study Completion Date : July 2023